Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2019 1
2020 4
2021 3
2022 6
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile Isolates.
Pensinger DA, Fisher AT, Dobrila HA, Van Treuren W, Gardner JO, Higginbottom SK, Carter MM, Schumann B, Bertozzi CR, Anikst V, Martin C, Robilotti EV, Chow JM, Buck RH, Tompkins LS, Sonnenburg JL, Hryckowian AJ. Pensinger DA, et al. Among authors: robilotti ev. Infect Immun. 2023 Feb 16;91(2):e0057022. doi: 10.1128/iai.00570-22. Epub 2023 Jan 24. Infect Immun. 2023. PMID: 36692308 Free PMC article.
COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease.
Moey MYY, Hennessy C, French B, Warner JL, Tucker MD, Hausrath DJ, Shah DP, DeCara JM, Bakouny Z, Labaki C, Choueiri TK, Dent S, Akhter N, Ismail-Khan R, Tachiki L, Slosky D, Polonsky TS, Awosika JA, Crago A, Wise-Draper T, Balanchivadze N, Hwang C, Fecher LA, Gomez CG, Hayes-Lattin B, Glover MJ, Shah SA, Gopalakrishnan D, Griffiths EA, Kwon DH, Koshkin VS, Mahmood S, Bashir B, Nonato T, Razavi P, McKay RR, Nagaraj G, Oligino E, Puc M, Tregubenko P, Wulff-Burchfield EM, Xie Z, Halfdanarson TR, Farmakiotis D, Klein EJ, Robilotti EV, Riely GJ, Durand JB, Hayek SS, Kondapalli L, Berg S, O'Connor TE, Bilen MA, Castellano C, Accordino MK, Sibel B, Weissmann LB, Jani C, Flora DB, Rudski L, Dutra MS, Nathaniel B, Ruíz-García E, Vilar-Compte D, Gupta S, Morgans A, Nohria A; COVID-19 and Cancer Consortium. Moey MYY, et al. Among authors: robilotti ev. Transl Oncol. 2023 Aug;34:101709. doi: 10.1016/j.tranon.2023.101709. Epub 2023 Jun 2. Transl Oncol. 2023. PMID: 37302348 Free PMC article.
Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients.
Laracy JC, Yan J, Steiger SN, Tan CA, Cohen N, Robilotti EV, Fender J, Cohen S, Korde N, Lee-Teh M, Noy A, Oved JH, Roeker LE, Shah G, Babady NE, Kamboj M, Seo SK. Laracy JC, et al. Among authors: robilotti ev. Haematologica. 2023 Nov 1;108(11):3058-3067. doi: 10.3324/haematol.2023.283015. Haematologica. 2023. PMID: 37345467 Free PMC article.
Determinants of COVID-19 disease severity in patients with cancer.
Robilotti EV, Babady NE, Mead PA, Rolling T, Perez-Johnston R, Bernardes M, Bogler Y, Caldararo M, Figueroa CJ, Glickman MS, Joanow A, Kaltsas A, Lee YJ, Lucca A, Mariano A, Morjaria S, Nawar T, Papanicolaou GA, Predmore J, Redelman-Sidi G, Schmidt E, Seo SK, Sepkowitz K, Shah MK, Wolchok JD, Hohl TM, Taur Y, Kamboj M. Robilotti EV, et al. Nat Med. 2020 Aug;26(8):1218-1223. doi: 10.1038/s41591-020-0979-0. Epub 2020 Jun 24. Nat Med. 2020. PMID: 32581323 Free PMC article.
Determinants of Severity in Cancer Patients with COVID-19 Illness.
Robilotti EV, Babady NE, Mead PA, Rolling T, Perez-Johnston R, Bernardes M, Bogler Y, Caldararo M, Figueroa-Ortiz C, Glickman M, Joanow A, Kaltsas A, Lee YJ, Lucca Bianchi A, Mariano A, Morjaria S, Nawar T, Papanicolaou GA, Predmore J, Redelman-Sidi G, Schmidt E, Seo SK, Sepkowitz K, Shah M, Wolchok JD, Hohl TM, Taur Y, Kamboj M. Robilotti EV, et al. medRxiv [Preprint]. 2020 May 8:2020.05.04.20086322. doi: 10.1101/2020.05.04.20086322. medRxiv. 2020. PMID: 32511541 Free PMC article. Updated. Preprint.
Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves.
Nawas MT, Shah GL, Feldman DR, Ruiz JD, Robilotti EV, Aslam AA, Dundas M, Kamboj M, Barker JN, Cho C, Chung DJ, Dahi PB, Giralt SA, Gyurkocza B, Lahoud OB, Landau HJ, Lin RJ, Mailankody S, Palomba ML, Papadopoulos EB, Politikos I, Ponce DM, Sauter CS, Shaffer BC, Scordo M, van den Brink MRM, Perales MA, Tamari R. Nawas MT, et al. Among authors: robilotti ev. Transplant Cell Ther. 2021 May;27(5):438.e1-438.e6. doi: 10.1016/j.jtct.2021.02.011. Epub 2021 Feb 14. Transplant Cell Ther. 2021. PMID: 33728417 Free PMC article.
Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study.
Satyanarayana G, Enriquez KT, Sun T, Klein EJ, Abidi M, Advani SM, Awosika J, Bakouny Z, Bashir B, Berg S, Bernardes M, Egan PC, Elkrief A, Feldman LE, Friese CR, Goel S, Gomez CG, Grant KL, Griffiths EA, Gulati S, Gupta S, Hwang C, Jain J, Jani C, Kaltsas A, Kasi A, Khan H, Knox N, Koshkin VS, Kwon DH, Labaki C, Lyman GH, McKay RR, McNair C, Nagaraj G, Nakasone ES, Nguyen R, Nonato TK, Olszewski AJ, Panagiotou OA, Puc M, Razavi P, Robilotti EV, Santos-Dutra M, Schmidt AL, Shah DP, Shah SA, Vieira K, Weissmann LB, Wise-Draper TM, Wu U, Wu JT, Choueiri TK, Mishra S, Warner JL, French B, Farmakiotis D. Satyanarayana G, et al. Among authors: robilotti ev. Open Forum Infect Dis. 2022 Feb 14;9(3):ofac037. doi: 10.1093/ofid/ofac037. eCollection 2022 Mar. Open Forum Infect Dis. 2022. PMID: 35198648 Free PMC article.
18 results